Industry News

Our news page will keep you informed of press releases and news articles on rapid and alternative microbiological method technologies and updates from technology suppliers.

Please click here to submit your news.

TessArae, LLC Taps L. Thomas Richards, M.D. as President

TessArae®, LLC, a privately held company, today announced that it has appointed Tom Richards as its new President. Dr. Richards has held faculty positions at Stanford University Medical Center and UCSF Medical Center, where he currently practices as an Assistant Clinical Professor in the Department of Emergency Medicine. Richards is a graduate of Harvard Medical School and Yale College.

"I am excited to be joining the team at TessArae," says Dr. Richards. "TessArae's technology makes it one of the most exciting molecular diagnostic companies today. In a single assay, it simultaneously detects and identifies hundreds of pathogens, confronting some of the most confounding problems in healthcare: nosocomial infections, antibiotic resistance, blood safety, food safety and pharmaceutical manufacturing quality assurance. That same technology allows it to analyze hundreds of human genetic mutations in a single assay, providing researchers and clinicians alike the chance to help patients understand their own genetic risks and inform their reproductive decisions. TessArae is positioned at an inflection point of very rapid growth."

Klaus Schafer, CEO of TessArae adds, "Tom brings a unique combination of skills to TessArae: he is a practicing academic physician with an investment banking background, public board experience and a deep grounding in Wall Street transactional finance. His medical and financial acumen will be a great contribution to our team and to our rapidly expanding customer base, which now includes the US, Canada, Mexico, China and the Middle East."

Post a Comment

Previous Post Next Post

Contact Form